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Background: Transapical transcatheter aortic valve implantation (TA-TAVI) has been associated with poorer outcomes as compared to 
transfemoral TAVI, partially explained by the higher risk profile of patients (pts) selected for TA approach, but few data exist on the issue of pain 
associated with thoracotomy and respiratory impairment. We aimed to determine the influence of different analgesic techniques (intercostal nerve 
blockade [INB] vs epidural analgesia [EA]) following TA-TAVI on clinical outcomes.
Methods: 135 consecutive pts with severe aortic stenosis (mean age: 79±8yrs; logEuroSCORE:19.0%[IQR:10-35%]) underwent TA-TAVI at our 
institution. A catheter for pain relief was placed either in a high thoracic epidural location (EA) or at the surgical incision for intercostal nerve 
blockade (INB), depending on the preference of the anesthesiologist. Pain degree (scale:1 to 10) and the need of supplemental analgesia were 
systematically recorded. All baseline, periprocedural and follow-up data were prospectively recorded.
Results: EA was used in 74 pts (55%) and INB in 61 pts (45%), with no differences in baseline or procedural characteristics. The maximal pain 
related to thoracotomy was higher in the INB group than in the EA group (4[3-5]) vs 2[1-3], p<0.0001). INB was associated with longer duration of 
orotracheal intubation (p=0.001), higher rate of re-intubation (22.9% vs 2.7%, p<0.001) and in-hospital pneumonia (14.8% vs. 2.7%, p=0.006). 
30-day mortality rate was higher in the INB group (19.7%) as compared to the EA group (2.7%), p=0.001. At a mean follow-up of 13±10 months, 
cumulative mortality remained higher in the INB group (36.1%) compared to the EA group (17.3%) (p=0.018). In multivariate analysis, the use of 
INB (HR:2.06[95%CI:1.34-3.18], p=0.001) and LogEuroSCORE (HR for each increase of 1%: 1.03[95%CI:1.01-1.05], p=0.036) were independent 
predictors of cumulative mortality.
Conclusions: EA provided superior analgesia than INB following TA-TAVI, and was associated with a dramatic reduction in respiratory complications 
and death. These results highlight the high clinical relevance of obtaining optimal analgesia following TA-TAVI to improve the results of this procedure
